BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018;10:133-148. [PMID: 30186577 DOI: 10.15171/mejdd.2018.103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li R, Li Z, Feng Y, Yang H, Shi Q, Tao Z, Cheng J, Lu X. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Apoptosis 2020;25:105-19. [DOI: 10.1007/s10495-019-01583-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wang C, Zhang X, Ling Q, Zheng S, Xu X. A model integrating donor gene polymorphisms predicts fibrosis after liver transplantation. Aging (Albany NY) 2020;13:1264-75. [PMID: 33291080 DOI: 10.18632/aging.202302] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Hou Y, Hsu S, Lee K. Decellularized liver matrix as substrates for rescue of acute hepatocytes toxicity. J Biomed Mater Res 2020;108:1592-602. [DOI: 10.1002/jbm.b.34506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Silva CM, Ferrari GD, Alberici LC, Malaspina O, Moraes KCM. Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism. Mol Cell Biochem 2020;468:129-42. [PMID: 32185674 DOI: 10.1007/s11010-020-03717-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, Toyoda M, Kanazawa N, Nakazawa T, Hori M, Uezumi A. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα. Cell Death Dis 2021;12:11. [PMID: 33414474 DOI: 10.1038/s41419-020-03353-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li H. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. J Ethnopharmacol 2020;251:112442. [PMID: 31891799 DOI: 10.1016/j.jep.2019.112442] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
8 Abdullah AS, El Sayed IET, El-Torgoman AMA, Alghamdi NA, Ullah S, Wageh S, Kamel MA. Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets. Biomedicines 2021;9:1767. [PMID: 34944582 DOI: 10.3390/biomedicines9121767] [Reference Citation Analysis]
9 Mamede KM, Sant'anna LB. Antifibrotic effects of total or partial application of amniotic membrane in hepatic fibrosis. An Acad Bras Cienc 2019;91:e20190220. [PMID: 31531535 DOI: 10.1590/0001-3765201920190220] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wang K, Guo Z, Bao Y, Pang Y, Li Y, He H, Song D. Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents. Molecules 2020;25:E4977. [PMID: 33121156 DOI: 10.3390/molecules25214977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Casas-Grajales S, Reyes-Gordillo K, Cerda-García-Rojas CM, Tsutsumi V, Lakshman MR, Muriel P. Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved. J Appl Toxicol 2019;39:1118-31. [PMID: 30883860 DOI: 10.1002/jat.3797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
13 Wang Q, Liu H, Zhu Z, Sheng Y, Du Y, Li Y, Liu J, Zhang J, Xing W. Feasibility of T1 mapping with histogram analysis for the diagnosis and staging of liver fibrosis: Preclinical results. Magn Reson Imaging 2021;76:79-86. [PMID: 33242591 DOI: 10.1016/j.mri.2020.11.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gu LH, Gu GX, Wan P, Li FH, Xia Q. The utility of two-dimensional shear wave elastography and texture analysis for monitoring liver fibrosis in rat model. Hepatobiliary Pancreat Dis Int 2021;20:46-52. [PMID: 32536521 DOI: 10.1016/j.hbpd.2020.05.008] [Reference Citation Analysis]